par Schettini, Francesco;Giuliano, Mario;Lambertini, Matteo
;Bartsch, Rupert;Pinato, David James;Onesti, Concetta Elisa;Harbeck, Nadia;Lüftner, Diana;Rottey, Sylvie;Van Dam, Peter P.A.;Zaman, Khalil;Mustacchi, Giorgio;Gligorov, Joseph;Awada, Ahmad
;Campone, Mario;Wildiers, Hans;Gennari, Alessandra;Tjan-Heijnen, Vivianne C G;Cortes, Javier;Locci, Mariavittoria;Paris, Ida;Mastro, Lucia Del;De Placido, Sabino;Martin, Miguel;Jerusalem, Guy;Venturini, Sergio;Curigliano, Giuseppe;Generali, Daniele
Référence Cancers (Basel), 13, 17, 4421
Publication Publié, 2021-09


Référence Cancers (Basel), 13, 17, 4421
Publication Publié, 2021-09
Article révisé par les pairs
Titre: |
|
Auteur: | Schettini, Francesco; Giuliano, Mario; Lambertini, Matteo; Bartsch, Rupert; Pinato, David James; Onesti, Concetta Elisa; Harbeck, Nadia; Lüftner, Diana; Rottey, Sylvie; Van Dam, Peter P.A.; Zaman, Khalil; Mustacchi, Giorgio; Gligorov, Joseph; Awada, Ahmad; Campone, Mario; Wildiers, Hans; Gennari, Alessandra; Tjan-Heijnen, Vivianne C G; Cortes, Javier; Locci, Mariavittoria; Paris, Ida; Mastro, Lucia Del; De Placido, Sabino; Martin, Miguel; Jerusalem, Guy; Venturini, Sergio; Curigliano, Giuseppe; Generali, Daniele |
Informations sur la publication: | Cancers (Basel), 13, 17, 4421 |
Statut de publication: | Publié, 2021-09 |
Sujet CREF: | Cancérologie |
Sciences bio-médicales et agricoles | |
Mots-clés: | Anthracyclines |
Breast cancer | |
Hormone receptor | |
Metastatic | |
Non‐pegylated liposomal doxorubicin | |
Triple negative | |
Note générale: | SCOPUS: re.j |
Langue: | Anglais |
Identificateurs: | urn:issn:2072-6694 |
info:doi/10.3390/cancers13174421 | |
info:scp/85114083798 |